Adma Biologics Inc (ADMA) receives a Strong buy rating from Raymond James
Adma Biologics Inc’s filing revealed that its Director Guiheen Lawrence P. unloaded Company’s shares for reported $0.17 million on Sep
Adma Biologics Inc’s filing revealed that its Director Guiheen Lawrence P. unloaded Company’s shares for reported $0.17 million on Sep
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Most of the major indices posted slim gains last week, although the DJIA was flat. The NASDAQ jumped 2.65% and
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.